GE HealthCare Technologies (GEHC) to Release Earnings on Wednesday

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) is expected to release its Q1 2025 earnings data before the market opens on Wednesday, April 30th. Analysts expect GE HealthCare Technologies to post earnings of $0.91 per share and revenue of $4.66 billion for the quarter. GE HealthCare Technologies has set its FY 2025 guidance at 4.610-4.750 EPS.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. On average, analysts expect GE HealthCare Technologies to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

GE HealthCare Technologies Stock Up 2.0 %

Shares of NASDAQ GEHC traded up $1.34 during midday trading on Friday, reaching $68.42. The company's stock had a trading volume of 5,508,561 shares, compared to its average volume of 3,264,407. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The stock has a market capitalization of $31.33 billion, a price-to-earnings ratio of 15.80, a PEG ratio of 3.19 and a beta of 1.14. The stock has a 50 day simple moving average of $76.59 and a 200-day simple moving average of $82.07.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.20%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.23%.

Analyst Ratings Changes

A number of research firms have recently issued reports on GEHC. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a report on Thursday, February 13th. Wells Fargo & Company upped their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $85.00 to $100.00 in a research report on Tuesday, March 11th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Piper Sandler dropped their target price on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $96.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.